by Simon Kung, MD | Sep 12, 2023 | Uncategorized
Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study Presented on Tuesday 12th September 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30...
by Gisèle Pickering, MD | Aug 8, 2023 | Uncategorized
Assessment of Initial Depressive State and Pain Relief With Ketamine in Patients With Chronic Refractory Pain Presented on Tuesday 8th August 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Marion Voute, Céline Lambert, Bruno Pereira,...
by Or Duek, PhD | Jul 26, 2023 | Uncategorized
Long term structural and functional neural changes following a single infusion of Ketamine in PTSD Presented on Tuesday 26th July 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Or Duek, Nachshon Korem, Yutong Li, Ben Kelmendi, Shelley...
by Jean-Philippe Miron, MD, PhD | Jun 27, 2023 | Uncategorized
Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case series Presented on Tuesday 27th June 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Olivier Payette,...
by Artemis Zavaliangos-Petropulu, PhD | Jun 13, 2023 | Uncategorized
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression Presented on Tuesday 13th June 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Brandon Taraku, Roger P. Woods, Michael Boucher,...
by Lena Vera Danyeli, PhD | May 23, 2023 | Uncategorized
Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine Presented on Tuesday 23rd May 2023 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Lena Vera Danyeli, Zümrüt...
